MoS 2 Nanozyme–Chlorella Hydrogels: Pioneering a Hepatocellular Carcinoma Integrative Therapy

Abstract Hepatocellular carcinoma (HCC) poses a formidable challenge to global health, and surgical resection is the predominant therapeutic strategy. However, the efficacy of postoperative adjuvant treatments is often compromised by the need to preserve liver function. The authors’ meta‐analysis reveals a significant correlation between impaired liver function and decreased survival rates in HCC patients, highlighting the critical need for interventions to protect liver function. To address this, an innovative injectable composite hydrogel system is engineered, designated MC@PHDA, which encapsulates Molybdenum disulfide MoS 2 nanozymes and Chlorella photosensitizers within a hyaluronic…

• NS
  Natural Science Foundation of Shanghai

  Award: 22ZR1477400
• SM
  Shanghai Municipal Health Commission

  Award: 202140335
• NN
  National Natural Science Foundation of China

  Award: 82072051